Optimizing Dosing of Oncology Drugs

E-ISSN： 1532-6535|96|5|572-579

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.96, Iss.5, 2014-11, pp. : 572-579

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of nonrandomized trials in the evaluation of oncology drugs

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 5, 2015-05 ,pp. : 502-507

John Wiley & Sons Inc

Access to resources Recommend Favorite

Optimizing Oncology Therapeutics Through Quantitative Translational and Clinical Pharmacology: Challenges and Opportunities

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 1, 2015-01 ,pp. : 37-54

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug‐coated balloons—the importance of packing and dosing antiproliferative drugs

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 2, 2015-08 ,pp. : 287-288

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cystatin C as a potential biomarker for dosing of renally excreted drugs

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 1, 2015-07 ,pp. : 20-27

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drugs pharmacokinetics in ICU patients: consequences of hypoalbuminemia upon drugs monitoring and dosing scheme

By Lagneau Franck Perbet Sébastien Delefosse Didier Wernet Anne Stocco Jeanick Marty Jean

Intensive Care Medicine, Vol. 30, Iss. 6, 2004-06 ,pp. : 1247-1247

Springer Publishing Company

Access to resources Recommend Favorite